How big is the China In Vitro Diagnostics Market?

The China In Vitro Diagnostics Market size is expected to reach USD 17.76 billion in 2024 and grow at a CAGR of 5.01% to reach USD 22.68 billion by 2029. Read More

What is the current China In Vitro Diagnostics Market size?

In 2024, the China In Vitro Diagnostics Market size is expected to reach USD 17.76 billion. Read More

Who are the key players in China In Vitro Diagnostics Market?

Autobio Diagnostics, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Maccura Biotechnology and Xiamen Boson Biotech are the major companies operating in the China In Vitro Diagnostics Market. Read More

What years does this China In Vitro Diagnostics Market cover, and what was the market size in 2023?

In 2023, the China In Vitro Diagnostics Market size was estimated at USD 16.87 billion. The report covers the China In Vitro Diagnostics Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the China In Vitro Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the key growth areas in the China IVD Market?

The key growth areas in the China IVD Market are a) Molecular diagnostics b) Immunoassays c) POCT (point-of-care testing) for rapid diagnoses Read More

What are the key growth drivers for the IVD market in China?

The key growth drivers for the IVD market in China are a) Rising healthcare spending b) Aging population c) Increasing focus on early disease detection Read More

China In Vitro Diagnostics Companies

This report lists the top China In Vitro Diagnostics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the China In Vitro Diagnostics industry.